Evaluation of the Clinical Relevance of the Anionic Glutathione-S-Transferase (GSTπ) and Multidrug Resistance (mdr-1) Gene Coexpression in Leukemias and Lymphomas

References

• Pastan I., Gottesman M. M. Multiple-drug resistance in human cancer. N. Engl. J. Med. 1987; 316: 1388–1393
   PubMed Web of Science ®Google Scholar
• Moscow J. A., Cowan K. M. Multidrug resistance. J. Natl. Cancer Inst. 1987; 80: 14–20
   Web of Science ®Google Scholar
• Fojo A. T., Ueda K., Salmon D. J., Poplack D. G., Gottesman M. M., Pastan I. Expression of a mul-tidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 1987; 84: 256–269
   PubMed Web of Science ®Google Scholar
• Tsuruo T. Mechanisms of multidrug resistance implications for therapy. Jpn. J. Cancer Res. 1988; 79: 285–296
   PubMedGoogle Scholar
• Deuchars K. L., Ling V. P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin. Oncol. 1989; 16: 156–165
   PubMed Web of Science ®Google Scholar
• Goldstein L. J., Galski H., Fojo A., Willingham M., Lai S. L., Gazdar A., Pirker R., Crist W., Brodeur G. M., Lieber M., Cossman J., Gottesman M. M., Pastan I. Expression of multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 1989; 81: 116–124
   PubMed Web of Science ®Google Scholar
• Nooter K., Herweijer H. Multidrug resistance (mdr) genes in human cancer. Br. J. Cancer 1991; 63: 663–669
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Sugimoto Y., Hamada H., Roninson I., Oku-Mura M., Adachi K., Morishima Y., Ohno R. Detection of multidrug resistance markers, P-glycoprotein and mdrl mRNA in human leukemia cells. Jpn. J. Cancer Res. 1987; 78: 1415–1419
   PubMedGoogle Scholar
• Holmes J., Jacobs A., Carter G., Janowska-Wieczoreck A., Padua R. A. Multidrug resistance in haemopoietic cell lines, myelodisplastic syndromes and acute my-eloblastic leukaemia. Br. J. Haematol. 1989; 72: 40–44
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y., Yoshimura A., Hanada S., Utsunomiya A., Makino T., Ishibashi K., Kodama M., Iwahashi M., Ar-Ima T., Akiyama S. I. Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 1990; 66: 868–873
   PubMed Web of Science ®Google Scholar
• Kuwazaru Y., Yoshimura A., Hanada S., Ichikawa M., Saito T., Uozumi K., Utsunomiya A., Arima T., Akiyama S. Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukemia cells in blast crisis. Br. J. Haematol. 1990; 74: 24–29
   PubMed Web of Science ®Google Scholar
• Sato H., Preisler H., Day R. MDR1 transcript level as an indication of resistant disease in acute myelogenous leukemia. Br. J. Haematol. 1990; 75: 340–345
   PubMed Web of Science ®Google Scholar
• Marie J. P., Zittoun R., Sikic B. I. Multidrug resistance (mdrl) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586–592
   PubMed Web of Science ®Google Scholar
• Michieli M., Giacca M., Fanin R., Damiani D., Geromin A., Baccarani M. mdrl gene amplification in acute lymphoblastic leukaemia prior to antileukaemic treatment. Br. J. Haematol. 1991; 78: 290–291
   PubMed Web of Science ®Google Scholar
• Michieli M., Damiani D., Geromin A., Michelutti A., Fanin R., Raspadori D., Russo D., Visani G., Dinota A., Pileri S., Tsuruo T., Grandi M., Baccarani M., Tura S. Overexpression of multidrug resistance-associated p-170 glycoprotein in acute non-lymphocytic leukemia. Eur. J. Haematol. 1992; 48: 87–92
   PubMed Web of Science ®Google Scholar
• Zhou D. C., Marie J. P., Suberville A. M., Zittoun R. Relevance of MDR 1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 1992; 6: 879–885
   PubMed Web of Science ®Google Scholar
• Marie J. P., Legrand O., Russo D., Zhou D. C., Suberville A. M., Zittoun R. Multidrug resistance (MDR) gene expression in acute non-lymphocytic leukemia. Sequential analysis. Leukemia and Lymphoma 1992; 8: 261–265
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute non-lymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473–476
   PubMed Web of Science ®Google Scholar
• Goasguen J. E., Dossot J. M., Fardel O., Le Mee F., Le Gall E., Leblay R., LePrise P. Y., Chaperon J., Fauchet R. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood 1993; 81: 2394–2398
   PubMed Web of Science ®Google Scholar
• Tiirikainen M. I., Elonen E., Ruutu T., Jansson S. E., Krusius T. Clinical significance of P-glycoprotein expression in acute leukaemia as analysed by immunocyto-chemistry. Eur. J. Haematol. 1993; 50: 279–285
   PubMed Web of Science ®Google Scholar
• Salmon S. E., Grogan I. M., Miller T. P., Dalton W. S. P-glycoprotein staining predicts intrinsic doxorubicin resistance in patients with myeloma and lymphoma. Blood 1988; 72: 256a
   Google Scholar
• Dalton W. S., Grogan T. M., Rybski J. A., et al. Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation. Blood 1989; 73: 747–752
   PubMed Web of Science ®Google Scholar
• Epstein J., Xiao H., Oba B. K. P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood 1989; 74: 913–917
   PubMed Web of Science ®Google Scholar
• Morrow C. S., Cowan K. H. Glutathione S-trans-ferases and drug resistance. Cancer Cells 1990; 2: 15–22
   PubMed Web of Science ®Google Scholar
• Tew K. D. The involvement of glutathione-S transferases in drug resistance. Anticancer drugs. Colloque INSERM, H. Tapiero, J. Robert, T. Lampidis. John Libby Eurotext Ltd, Londres, Paris 1989; 103–112, INSERM 191
   Google Scholar
• Kramer R. A., Zakher J., Kim G. Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science 1988; 241: 694–697
   PubMed Web of Science ®Google Scholar
• Carmichael J., Forrester L. M., Lewis A. D., Hayes J. D., Hayes P. C., Wolf C. R. Glutathione S-trans-ferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis 1988; 9: 1617–1621
   PubMed Web of Science ®Google Scholar
• Riou G., Barrois M., Zhou D. Expression of anionic glutathione S transferase (GST) gene in carcinomas of the uterine cervix and in normal cervices. Br. J. Cancer 1990; 62: 191–194
   Google Scholar
• Moorghen M., Cairns J., Forrester L. M., Hayes J. D., Hall A., Cattan A. R., Wolf C. R., Harris A. L. Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis 1991; 12: 13–17
   PubMed Web of Science ®Google Scholar
• Russo D., Marie J. P., Zhou D. C., Faussat-Suberville A. M., Delmer A., Maisonneuve L., Baccarani M., Zit-Toun R. Coexpression of anionic glutathione-s-trans-ferase (GST) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias. Leukemia 1994, in press
   PubMedGoogle Scholar
• Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragment to high specific activity. Ann. Biochem. 1983; 132: 6–13
   Web of Science ®Google Scholar
• Russo D., Marie J. P., Delmer A., Zhou D. C., Suber-Ville A. M., Baccarani M., Zittoun R. DNA-topoisomerase I and II: biologic features and their role in drug resistance. Haematologica 1993; 78: 201–207
   PubMedGoogle Scholar
• Deffie A. M., Alam T., Seneviratne C., Beenken S. W., Batra J. K., Shea T. C., Henner W. D., Goldenberg G. J. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res. 1988; 48: 3595–3602
   PubMed Web of Science ®Google Scholar
• Lefrevre D., Riou J. F., Ahomadegbe J. C., Zhou D. Y., Bernard J., Riou G. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoiso-merase I and acidic glutathione S transferase. Biochem. Pharmacol. 1991; 41: 1967–1979
   PubMed Web of Science ®Google Scholar
• Lau D. H. M., Lewis A. D., Ehsan M. N., Sikic B. I. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cy-anomorpholino doxoburicin. Cancer Res. 1991; 51: 5181–5187
   PubMed Web of Science ®Google Scholar
• Holmes J., Wareing C., Jacobs A., Hayes J. D., Padua R. A., Wolf C. R. Glutathione-S-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data. Br. J. Cancer 1990; 62: 209–212
   PubMed Web of Science ®Google Scholar
• Kim R., Hirabayashi N., Nishiyama M., Saeki S., Toge T., Okada K. Expression of MDR1, GST and topoisomerase II as an indicator or clinical response to adriamycin. Anticancer Res. 1991; II: 429–432
   Google Scholar
• Bourhis J., Hartmann O., DeVathaire F., Terrier-La-Combe M. J., Boccon-Gibod L., Lemerle J., Riou G., Bdnard J. Expression of mdrl and GST genes in 35 advanced neuroblastomas. Adv. Neuroblastoma Res. 1991; 3: 127–134
   Google Scholar
• Satta T., Isobe K., Yamauchi M., Nakashima I., Takagi H. Expression of MDR1 and glutathione S transferase- genes and chemosensitivities in human gastrointestinal cancer. Cancer 1992; 69: 941–946
   PubMed Web of Science ®Google Scholar
• Moscow J. A., Fairchild C. R., Madden M. J., Ransom D. T., Wieand H. S., O'Brien E. E., Poplack D. G., Coss-Man J., Myers C. E., Cowan K. H. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989; 49: 1422–1428
   PubMed Web of Science ®Google Scholar
• McQuaid S., McCann S., Daly P., Lawlor E., Humphries P. Observations on the transcriptional activity of the glutathione S-transferase tr gene in human haematological malignancies and in the peripheral leucocytes of cancer patients under chemotherapy. Br. J. Cancer 1989; 59: 540–550
   PubMed Web of Science ®Google Scholar
• Cheng A. L., Su I. J., Chen Y. C., Lee T. C., Wang C. H. Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Ep-stein-Barr virus, immunophenotypes, and other predisposing factors. J. Clin. Oncol. 1993; II: 109-H5
   Google Scholar